Relevance Score | ABIN | Application | Konjugat | Host | Isotype | Epitope | Hersteller | Clonality | References | Details |
---|---|---|---|---|---|---|---|---|---|---|
12.4843445 | ABIN802548 | IF (p) IHC (p) WB | Rabbit | IgG | AA 165-210, pSer186 | Anmelden zum Anzeigen | Polyclonal | 0 | ||
12.4843445 | ABIN214211 | IHC (fro) IHC (rs) IHC (p) IP | Mouse | IgG1 | AA 154-167 | Anmelden zum Anzeigen | SMP14 | 0 | ||
12.4843445 | ABIN743753 | IF (p) IHC (p) WB | Rabbit | IgG | pSer166 | Anmelden zum Anzeigen | Polyclonal | 0 | ||
1 | ABIN180331 | IHC (fro) IHC (p) IP WB | Mouse | IgG1 | AA 154-167 | Anmelden zum Anzeigen | SMP14 | 3 | ||
1 | ABIN319417 | IF IHC (p) WB | Rabbit | Ser166 | Anmelden zum Anzeigen | Polyclonal | 3 | |||
1 | ABIN802533 | IF (p) IHC (p) WB | Rabbit | IgG | pThr218 | Anmelden zum Anzeigen | Polyclonal | 0 | ||
1 | ABIN802557 | IHC (p) WB | HRP | Rabbit | IgG | AA 165-210, pSer186 | Anmelden zum Anzeigen | Polyclonal | 0 | |
1 | ABIN802542 | IHC (p) WB | HRP | Rabbit | IgG | pThr218 | Anmelden zum Anzeigen | Polyclonal | 0 | |
1 | ABIN736830 | IHC (p) WB | HRP | Rabbit | IgG | AA 440-491 | Anmelden zum Anzeigen | Polyclonal | 0 | |
1 | ABIN802550 | IHC (p) WB | Biotin | Rabbit | IgG | AA 165-210, pSer186 | Anmelden zum Anzeigen | Polyclonal | 0 | |
1 | ABIN802535 | IHC (p) WB | Biotin | Rabbit | IgG | pThr218 | Anmelden zum Anzeigen | Polyclonal | 0 | |
1 | ABIN736823 | IHC (p) WB | Biotin | Rabbit | IgG | AA 440-491 | Anmelden zum Anzeigen | Polyclonal | 0 | |
1 | ABIN5674533 | IF IHC (p) WB | Rabbit | AA 164-168 | Anmelden zum Anzeigen | Polyclonal | 0 | |||
1 | ABIN953362 | IHC (p) WB | Mouse | IgG1 | AA 154-167 | Anmelden zum Anzeigen | SMP14 | 3 |
General |
|
---|---|
Antigen | Mdm2, p53 E3 Ubiquitin Protein Ligase Homolog (Mouse) (MDM2) Antikörper |
Epitop | AA 440-491 Alternativen |
Reaktivität | Human, Maus, Ratte (Rattus) Alternativen |
Wirt | Kaninchen Alternativen |
Klonalität | |
Konjugat | Dieser MDM2 Antikörper ist unkonjugiert Alternativen |
Applikation |
Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB)
Alternativen
|
Hersteller | Anmelden zum Anzeigen |
Produktdetails anti-MDM2 AntikörperTarget Details MDM2 Anwendungsinformationen Handhabung Bilder |
|
Reinigung | Purified by Protein A. |
Immunogen | KLH conjugated synthetic peptide derived from human MDM2 |
Isotyp | IgG |
Target Details MDM2Produktdetails anti-MDM2 Antikörper Anwendungsinformationen Handhabung Bilder zurück nach oben |
|
Antigen | |
Andere Bezeichnung | Mdm2 (MDM2 Antibody Abstract) |
Hintergrund |
E3 ubiquitin-protein ligase that mediates ubiquitination of p53/TP53, leading to its degradation by the proteasome. Inhibits p53/TP53- and p73/TP73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. Also acts as a ubiquitin ligase E3 toward itself and ARRB1. Permits the nuclear export of p53/TP53. Promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma RB1 protein. Inhibits DAXX-mediated apoptosis by inducing its ubiquitination and degradation. Component of the TRIM28/KAP1-MDM2-p53/TP53 complex involved in stabilizing p53/TP53. Also component of the TRIM28/KAP1-ERBB4-MDM2 complex which links growth factor and DNA damage response pathways. Mediates ubiquitination and subsequent proteasome degradation of DYRK2 in nucleus. Ubiquitinates IGF1R and SNAI1 and promotes them to proteasomal degradation. Subcellular location: Cytoplasm, Nucleus Synonyms: HDMX, hdm2, ACTFS, E3 ubiquitin-protein ligase Mdm2, Double minute 2 protein, Oncoprotein Mdm2, p53-binding protein Mdm2, MDM2 |
Gen-ID | 4193 |
UniProt | Q00987 |
Pathways | p53 Signalweg, PI3K-Akt Signalweg, Zellzyklus, Fc-epsilon Rezeptor Signalübertragung, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Autophagie |
AnwendungsinformationenProduktdetails anti-MDM2 Antikörper Target Details MDM2 Handhabung Bilder zurück nach oben |
|
Applikationshinweise |
WB 1:100-1000 IHC-P 1:100-500 IF(IHC-P) 1:50-200 |
Beschränkungen | Nur für Forschungszwecke einsetzbar |
HandhabungProduktdetails anti-MDM2 Antikörper Target Details MDM2 Anwendungsinformationen Bilder zurück nach oben |
|
Format | Liquid |
Konzentration | 1 μg/μL |
Buffer | Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide. |
Konservierungsmittel | Sodium azide |
Vorsichtsmaßnahmen | This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only. |
Lagerung | -20 °C |
Informationen zur Lagerung | Store at -20°C |
Haltbarkeit | 12 months |
BilderProduktdetails anti-MDM2 Antikörper Target Details MDM2 Anwendungsinformationen Handhabung zurück nach oben |
|
Bilder des Herstellers |
![]() |
|
Chargennummer | 110602 |
Validierte Anwendung | Immunofluorescence |
Positivkontrolle | Human breast carcinoma |
Negativkontrolle | Pig muscle tissue (non-reactive species) |
Bewertung | Signal was detected in positive control sample and not in negative control sample. Note low levels of background in negative control and isotype control samples. |
Primärantikörper |
|
Isotypkontrolle |
|
Sekundärantikörper |
|
Kontrollen |
|
Protokoll |
|
Anmerkungen | - MDM2 on pig tissues were negative and MDM2 on human breast CA tissues showed nuclei staining, although with some faint cytoplasmic staining. |
Validierungsbilder |
|